NCT01721928View on ClinicalTrials.gov

Norwegian Intensive Care Unit Dalteparin Effect Study

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

December 3, 2012

Primary Completion Date

June 2, 2016

Study Completion Date

March 1, 2017

Conditions
Acute Kidney InjuryDeep Venous Thrombosis
Interventions
DEVICE

Continuous venovenous hemodialysis

Continuous venovenous hemodialysis

Trial Locations (1)

0540

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Oslo University Hospital

OTHER

NCT01721928 - Norwegian Intensive Care Unit Dalteparin Effect Study | Biotech Hunter | Biotech Hunter